<code id='DE466851AF'></code><style id='DE466851AF'></style>
    • <acronym id='DE466851AF'></acronym>
      <center id='DE466851AF'><center id='DE466851AF'><tfoot id='DE466851AF'></tfoot></center><abbr id='DE466851AF'><dir id='DE466851AF'><tfoot id='DE466851AF'></tfoot><noframes id='DE466851AF'>

    • <optgroup id='DE466851AF'><strike id='DE466851AF'><sup id='DE466851AF'></sup></strike><code id='DE466851AF'></code></optgroup>
        1. <b id='DE466851AF'><label id='DE466851AF'><select id='DE466851AF'><dt id='DE466851AF'><span id='DE466851AF'></span></dt></select></label></b><u id='DE466851AF'></u>
          <i id='DE466851AF'><strike id='DE466851AF'><tt id='DE466851AF'><pre id='DE466851AF'></pre></tt></strike></i>

          首页 >  知识 > 正文

          拟回药业万股双鹭购2

            双鹭药业(行情,双鹭 问诊)今日发布回购股票方案,计划以不超过45元/股的药业价格回购公司股份,回购总金额最高不超过1亿元。购万股以双鹭药业昨日收盘价41.88元计算,双鹭回购价格较现价溢价7.45%。药业

            根据预案,购万股双鹭药业拟通过深交所集中竞价交易方式实施回购,双鹭回购的药业股份将注销,。购万股在回购资金总额不超过1亿元、双鹭回购价格不超过45元的药业条件下,预计回购股份约222.22万股,购万股占总股本约0.49%。双鹭

            以双鹭药业2014年一季报的药业财务数据为基础,按照回购金额1亿元、购万股回购价格45元/股测算,此次回购完成后公司每股收益将提高0.49%,净资产收益率提高0.23%,业绩指标得到一定程度提升。

          标签:双鹭药业|购价格|0.49%责任编辑:杜思思 杜思思